Pharma Equity Group A/S Stock

Pharma Equity Group A/S P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Pharma Equity Group A/S (PEG.CO) as of Aug 15, 2026 is -6.55. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -5.06 — a change of 29.44% (lower).

P/CF

-6.55

YoY

29.44%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Pharma Equity Group A/S is 2026 -6.55 . P/CF (Price-to-Cash-Flow Ratio) of Pharma Equity Group A/S was 2025 -5.06 . It decreases by 29.44% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

P/CF (Price-to-Cash-Flow Ratio) of Pharma Equity Group A/S is -6.55 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Pharma Equity Group A/S changed from -5.06 to -6.55, representing a 29.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Pharma Equity Group A/S

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Pharma Equity Group A/S